Integration of retroviral cDNA into a host cell chromosome is a central feature of viral replication, but the determinants of integration target site selection remain uncertain. We have taken advantage of the draft human genome sequence to map sites of HIV cDNA integration and assess the relationship between integration acceptor sites and chromosomal features. Mapping of 524 independent sites of HIV cDNA integration in SupT1 cells revealed that 69% of integration sites were in transcription units, indicating that active genes are favored as targets. Transcriptional profiling of the target cells revealed that transcriptional activity correlated with targeting of genes for integration. Integration hotspots were also detected, including a 2 kb chromosomal region containing 5 independent integrated proviruses, 1% of the integration events analyzed. These data reveal that HIV integration is highly biased in the human genome, providing new perspective on HIV integration mechanism. These data are also important for assessing the safety of retroviral vectors in gene therapy, and the use of retroviruses as insertional mutagenesis. To extend this study, the following specific aims will be addressed: To characterize integration site selection in primary human cells; To characterize integration site selection by MLV; To investigate the mechanisms directing integration targeting; and to characterize integration sites in patient samples.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI052845-05
Application #
6891263
Study Section
Special Emphasis Panel (ZRG1-AARR-1 (11))
Program Officer
Sharma, Opendra K
Project Start
2002-06-01
Project End
2007-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
5
Fiscal Year
2005
Total Cost
$286,481
Indirect Cost
Name
University of Pennsylvania
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Clarke, Erik L; Connell, A Jesse; Six, Emmanuelle et al. (2018) T cell dynamics and response of the microbiota after gene therapy to treat X-linked severe combined immunodeficiency. Genome Med 10:70
Veenhuis, Rebecca T; Kwaa, Abena K; Garliss, Caroline C et al. (2018) Long-term remission despite clonal expansion of replication-competent HIV-1 isolates. JCI Insight 3:
Sherman, Eric; Nobles, Christopher; Berry, Charles C et al. (2017) INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes. Mol Ther Methods Clin Dev 4:39-49
Chehoud, Christel; Stieh, Daniel J; Bailey, Aubrey G et al. (2017) Associations of the vaginal microbiota with HIV infection, bacterial vaginosis, and demographic factors. AIDS 31:895-904
Berry, Charles C; Nobles, Christopher; Six, Emmanuelle et al. (2017) INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions. Mol Ther Methods Clin Dev 4:17-26
Gupta, Kushol; Turkki, Vesa; Sherrill-Mix, Scott et al. (2016) Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase. PLoS Biol 14:e1002584
Feng, Lei; Dharmarajan, Venkatasubramanian; Serrao, Erik et al. (2016) The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency. ACS Chem Biol 11:1313-21
Ocwieja, Karen E; Sherrill-Mix, Scott; Liu, Changchun et al. (2015) A reverse transcription loop-mediated isothermal amplification assay optimized to detect multiple HIV subtypes. PLoS One 10:e0117852
Pache, Lars; Dutra, Miriam S; Spivak, Adam M et al. (2015) BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency. Cell Host Microbe 18:345-53
Aiyer, Sriram; Rossi, Paolo; Malani, Nirav et al. (2015) Structural and sequencing analysis of local target DNA recognition by MLV integrase. Nucleic Acids Res 43:5647-63

Showing the most recent 10 out of 72 publications